We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
5-Lipoxygenase-mediated mitochondrial damage and apoptosis of mononuclear cells in ESRD patients.
- Authors
Maccarrone, Mauro; Taccone-Gallucci, Massimo; Finazzi-Agrò, Alessandro
- Abstract
5-Lipoxygenase-mediated mitochondrial damage and apoptosis of mononuclear cells in ESRD patients. Background. 5-Lipoxygenase activity is enhanced in peripheral blood mononuclear cells (PBMC) from end-stage renal disease (ESRD) patients on maintenance hemodialysis (HD), leading to lipoperoxidation and reactive oxygen species formation. These effects are prevented by vitamin E, which inhibits 5-lipoxygenase activity. The present study was designed to test the possibility that 5-lipoxygenase activation might cause mitochondrial damage and cytochrome c release, ultimately leading PBMC to apoptosis. Methods. Apoptosis, mitochondrial uncoupling, and cytochrome c release were investigated in PBMC from 16 healthy volunteers and 16 ESRD patients on maintenance HD with cuprammonium rayon (CL-S) membranes in a two-step crossover study: after a four-week treatment with vitamin E-coated cuprammonium rayon (CL-E) membranes, and again after a four-week treatment with oral vitamin E. Results. Compared to healthy controls, PBMC from ESRD patients showed a ∼threefold increase in mitochondrial uncoupling and cytochrome c release (within 4 and 8 hours, respectively), followed by a ∼threefold increase in apoptotic body formation (within 48 hours). Regardless of the administration route, vitamin E reduced mitochondrial uncoupling, cytochrome c release and apoptosis of mononuclear cells, as did the 5-lipoxygenase inhibitor eicosatetraynoic acid. Conversely, the cyclooxygenase inhibitor indomethacin was ineffective. Conclusions. Reported data suggest that the 5-lipoxygenase branch of the arachidonate cascade is only responsible for mitochondrial disruption and apoptosis of PBMC of ESRD patients, and that vitamin E may be helpful in the control of oxidative stress-related disease in these subjects, independent of the administration route.
- Subjects
CHRONIC kidney failure; MITOCHONDRIAL pathology; APOPTOSIS; HEMODIALYSIS
- Publication
Kidney International Supplement, 2003, Issue 84, p33
- ISSN
0098-6577
- Publication type
Article
- DOI
10.1046/j.1523-1755.63.s84.26.x